Triple Negative Breast Cancer

September 2, 2025

Update on Strategies to Improve Treatment for Triple Negative Breast Cancer

Charles H. Weaver, MD
August 29, 2025

Immune Checkpoint Inhibitor Side Effects & Toxicity More Common Than Reported

Charles H. Weaver, MD
December 20, 2024

Neoadjuvant Camrelizumab Combination Improves Pathologic Complete Response in Early Triple-Negative Breast Cancer

Charles H. Weaver, MD
November 17, 2023

Truqap (capivasertib) in Breast Cancer

Charles H. Weaver, MD
October 24, 2023

Keytruda & Other Checkpoint Inhibitors for Triple Negative Breast Cancer

Charles H. Weaver, MD
September 30, 2023

Breast Cancer – Are You Aware?

Charles H. Weaver, MD
August 17, 2023

The Sense of Urgency When Diagnosed with Breast Cancer

Charles H. Weaver, MD
April 23, 2021

Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer Reduces Recurrence Risk

Charles H. Weaver, MD
February 21, 2021

Dr. Ramaswamy Answers Questions About Triple-Negative Breast Cancer

Charles H. Weaver, MD
February 21, 2021

PARP Inhibitors Slow Spread of Breast Cancer Caused by Inherited BRCA Mutations

Charles H. Weaver, MD
December 12, 2020

Trilaciclib for Triple-Negative Breast Cancer

Charles H. Weaver, MD
August 18, 2020

Treatment of Early Stage TNBC

Charles H. Weaver, MD